UW Medicine will expand its use of Microsoft Amalga Unified Intelligence System, to support multiple clinical and research initiatives across the health organization. UW Medicine has purchased a perpetual license to use Amalga UIS to improve clinical care, quality and human subjects-approved research by providing clinical and translational researchers with faster and more complete access to electronic data stored on disparate systems across the UW Medicine health system.
UW Medicine and Microsoft also agreed to leverage their respective expertise in medicine and software development to maximize development of technologies that improve the delivery of healthcare. To that end, both parties have signed a memorandum of understanding under which they’ll work together in the area of biomedical informatics technology development.
For the past two years, UW Medicine’s Institute of Translational Health Sciences (ITHS) has been evaluating Amalga UIS as a tool to accelerate and improve translational research, which involves more quickly moving knowledge and discovery gained from the basic sciences to its app in clinical and community settings.